ESTOMATOLOGÍA
Departament
Instituto de Salud Carlos III
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Salud Carlos III (4)
2024
-
Chronic melatonin treatment improves obesity by inducing uncoupling of skeletal muscle SERCA-SLN mediated by CaMKII/AMPK/PGC1α pathway and mitochondrial biogenesis in female and male Zücker diabetic fatty rats
Biomedicine and Pharmacotherapy, Vol. 172
-
Corrigendum to “Chronic melatonin treatment improves obesity by inducing uncoupling of skeletal muscle SERCA-SLN mediated by CaMKII/AMPK/PGC1α pathway and mitochondrial biogenesis in female and male Zücker diabetic fatty rats” [Biomed. Pharmacother. 172 (2024) 116314] (Biomedicine & Pharmacotherapy (2024) 172, (S0753332224001951), (10.1016/j.biopha.2024.116314))
Biomedicine and Pharmacotherapy
2021
2020
-
Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)
European Journal of Cancer Care, Vol. 29, Núm. 4